Skip to main content
. 2020 Dec 29;43:e2021004. doi: 10.4178/epih.e2021004

Figure 1.

Figure 1.

Description of data source and selection of the cohort of coronavirus disease 2019 (COVID-19) patients with hypertension. HIRA, Health Insurance Review and Assessment Service; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.